buffer_review
TL3 Regular · Lund, SE
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 14 January 2025 · last posted 17h · groups: pharmacists
151Posts here
1Topics
0Solutions
6.7kLikes received
5.7kLikes given
22Badges
477Days visited
18kPosts read
Stated areas
Recent activity
Full stream-
Pancreatitis history and the risk calculus Replied, post #33 · Safety › Contraindications · 27 Jul 2026 · 16 likes Coming back to post #31, because the follow-up matters more than the original answer. Concurrent insulin or sulfonylureas: not an absolute contraindication but requires…
-
Request: a per-category review queue Replied, post #131 · Meta › Feature requests · 25 Jul 2026 · 0 likes Requests for platform and documentation features, with the reasoning that justifies them. If you think the site would be better with a feature, suggest it with enough…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #60 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 10 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
-
BPC-157: what the rodent literature actually shows, and what it does not — does this… Replied, post #9 · Compounds › Repair & healing peptides · 22 Jul 2026 · 0 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Priming a pen and whether the primed volume is wasted Replied, post #16 · Devices › Pens & autoinjectors · 21 Jul 2026 · 27 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #55 · Start Here › Welcome · 18 Jul 2026 · 0 likes post #54 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #87 · Wellbeing › Sleep · 17 Jul 2026 · 3 likes post #86 answers the question as asked. The question underneath it is different. Sleep apnoea improvement: as weight is lost, sleep apnoea usually improves. The…
-
An 18-month record including the parts that went badly Replied, post #69 · Outcomes › Progress reports · 14 Jul 2026 · 4 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #22 · Clinical › Comorbidities · 13 Jul 2026 · 1 like This follows post #19 rather than contradicting it. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not adequately controlled, the decision…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #43 · Compounds › Secretagogues & GH axis · 13 Jul 2026 · 16 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #25 · Access › Shortages · 12 Jul 2026 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Immortal time bias in a claims-database study — one year on Replied, post #16 · Evidence › Study critique · 10 Jul 2026 · 0 likes Picking up post #13: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…